We provide experience-based consulting services for Biotech, Pharma and Medtech clients globally. Technical consulting, project management, strategy and management consulting, market and opportunity analyses are some of our core areas of expertise.go
Ventac Partners has a global network of Life Science investors in Europe, US and Asia as well as expertise in founding and growing companies on behalf of clients. Unlike other consulting agencies, we also found, actively manage, grow and help exit innovative Portfolio Companies co-owned with partners & investors.go
We offer extensive buy and sell-side transaction experience with a truly international reach in virtually all Life Science sectors. Our specialties include in- and out-licensing, mergers & acquisitions, business development and marketing collaborations in all continents.go
Idogen AB, a Ventac Portfolio company, reports that the company has made a breakthrough in the development of the company’s tolerogenic vaccine. Idogen has now in a proof-of-concept study shown that the company’s technology successfully has been confirmed in human cells. These positive results represent an important step in the development of a tolerogenic vaccine and an important step closer to treating patients with severe hemophilia A affected by factor VIII antibodies. For more information, please follow this link.
Ventac Partners is very excited to announce its latest portfolio company, Orbit Genomics, focused on often ignored micro-satellites (short repeat sequences of DNA) as a diagnostic tool. Orbit’s first indication will be on brain cancer. Additional applications will include other cancer and non-cancer indications as well as a new tool for companion diagnostics. For more information, please visit www.orbitgenomics.com.
Ventac Partners Melya Hughes Crameri will be attending the J.P. Morgan 35th Annual Healthcare Conference 2017 in San Francisco (January 9-13)
Ventac Partners Mikael Oerum and Scott Woodward will be attending the Biotech Showcase conference in San Francisco, California (January 9-11)
Ventac Partners Melya Hughes Crameri will be attending BioFIT in Lille, France (Nov. 30 – Dec. 1)